No surprise your back Bosco. 9 consecutive quarters of losses eh? The new management started pulling apart the old management 2 years ago, with Matt Weston the CEO only departing the scene in August 2018. The company started to transition to Med Cann properly with the Cannvalate deal in March 19 and then Sud’s appointment in July. So this company has built a multi pronged world class programme in a year with a truckload of news about to follow in l
ess than a year.So what’s clear to me is that the usual “peak period” has been decapitated by Covid 19 which makes sense because there is not a sporting competition in the world at the moment that is active (outside of the Unibet home darts competition) with the bulk of the revenue continuing to come from the growth in oils sales - sorry Bosco that the BOD cant control Covid 19 and its influence on sporting competitions.
What you’re saying is no different to last time you posted and so I’ll state the same - that is, you gotta sucked out in the great Covid 19 shakeout of 2020 and sold at or near the bottom. You didn’t sell in the 6’s at all, refer the link to the following post where you do nothing but sing the praises and potential of the company just prior to “peak COVID “ and at the time of posting the stock was still 5.1:
https://hotcopper.com.au/posts/43339891/singleThis company is running multiple clinical trials, an advisory board, consultants and has 6000 units of product on the way and if you add back the receivable from Cannvalate has circa $4.5m left in cash after raising $5m in October, to me that’s remarkable!
Maybe, just maybe its because the BOD has a SIGNIFICANT AMOUNT OF STOCK.
Actually, can you point out another med Cann company or biotech thats involved in clinical development that has spent that little cash? Just as an aside but assuming 6% capital raising fees Plus GST the net proceeds of that raise would’ve been $4,670,000.
I told you I decided to start posting because of people like you. Say it for what it is, you made a mistake and sold at the bottom. No disgrace, many did but don’t call the company lifestyle people when they’re as frugal as any company I’ve been invested in - to say otherwise is disparaging at least and slanderous at worst.
As an aside, good to see it looks as though the Animal testing re IHL-675A is about to start imminently.
Ted
